{
  "target_name": "KRAS",
  "paper_count": 30,
  "paper_count_year": {
    "1988": [1, 1, 2],
    "1989": [1, 0, 2],
    "1991": [1, 1, 0],
    "1993": [1, 0, 6],
    "1997": [1, 4, 2],
    "1998": [1, 5, 2],
    "2005": [1, 0, 13],
    "2006": [2, 8, 5],
    "2007": [3, 6, 4],
    "2008": [1, 6, 15],
    "2009": [3, 15, 32],
    "2010": [6, 20, 34],
    "2011": [6, 17, 43],
    "2012": [11, 18, 45],
    "2013": [9, 16, 59],
    "2014": [11, 13, 57],
    "2015": [15, 17, 42],
    "2016": [15, 22, 43],
    "2017": [13, 15, 57],
    "2018": [23, 20, 39],
    "2019": [34, 23, 31],
    "2020": [35, 24, 45],
    "2021": [34, 40, 37],
    "1911": [0, 1, 0],
    "1935": [0, 1, 0],
    "1940": [0, 1, 0],
    "1946": [0, 1, 0],
    "1949": [0, 2, 0],
    "1966": [0, 1, 0],
    "1971": [0, 1, 0],
    "1972": [0, 2, 1],
    "1976": [0, 1, 0],
    "1981": [0, 2, 1],
    "1982": [0, 1, 2],
    "1983": [0, 1, 3],
    "1987": [0, 4, 3],
    "1990": [0, 3, 3],
    "1992": [0, 2, 3],
    "1994": [0, 1, 7],
    "1995": [0, 3, 3],
    "1996": [0, 2, 0],
    "1999": [0, 4, 4],
    "2000": [0, 1, 4],
    "2001": [0, 2, 1],
    "2002": [0, 3, 6],
    "2003": [0, 9, 1],
    "2004": [0, 3, 7],
    "1832": [0, 0, 1],
    "1837": [0, 0, 1],
    "1894": [0, 0, 1],
    "1902": [0, 0, 1],
    "1903": [0, 0, 1],
    "1904": [0, 0, 2],
    "1909": [0, 0, 1],
    "1912": [0, 0, 1],
    "1914": [0, 0, 1],
    "1921": [0, 0, 3],
    "1922": [0, 0, 1],
    "1932": [0, 0, 1],
    "1939": [0, 0, 1],
    "1943": [0, 0, 3],
    "1945": [0, 0, 1],
    "1947": [0, 0, 1],
    "1948": [0, 0, 1],
    "1951": [0, 0, 2],
    "1958": [0, 0, 1],
    "1960": [0, 0, 1],
    "1961": [0, 0, 1],
    "1967": [0, 0, 3],
    "1968": [0, 0, 1],
    "1969": [0, 0, 2],
    "1970": [0, 0, 2],
    "1973": [0, 0, 2],
    "1977": [0, 0, 1],
    "1978": [0, 0, 1],
    "1979": [0, 0, 2],
    "1980": [0, 0, 2],
    "1984": [0, 0, 1],
    "1985": [0, 0, 2],
    "1986": [0, 0, 2]
  },
  "drug_molecule_count": 17,
  "drug_molecule_paper": [
    {
      "id": 0,
      "paper_title": "One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS",
      "paper_author": [
        "Juergen Ramharter",
        "Dirk Kessler",
        "Peter Ettmayer",
        "Marco H. Hofmann",
        "Thomas Gerstberger",
        "Michael Gmachl",
        "Tobias Wunberg",
        "Christiane Kofink",
        "Michael Sanderson",
        "Heribert Arnhof",
        "Gerd Bader",
        "Klaus Rumpel",
        "Andreas Zöphel",
        "Renate Schnitzer",
        "Jark Böttcher",
        "Jonathan C. O’Connell",
        "Rachel L. Mendes",
        "David Richard",
        "Nikolai Pototschnig",
        "Irene Weiner",
        "Wolfgang Hela",
        "Katja Hauer",
        "Daniela Haering",
        "Lyne Lamarre",
        "Bernhard Wolkerstorfer",
        "Christian Salamon",
        "Patrick Werni",
        "Silvia Munico-Martinez",
        "Reiner Meyer",
        "Matthew D. Kennedy",
        "Norbert Kraut",
        "Darryl B. McConnell"
      ],
      "paper_year": 2021,
      "paper_institution": "",
      "paper_cited": 3,
      "doi": "10.1021/acs.jmedchem.0c01949",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-10/acs.jmedchem.0c01949/20210520/images/large/jm0c01949_0015.jpeg",
      "compound_count": 14,
      "compound_name": "BI-3406",
      "compound_name_drug": "BI-3406",
      "compound_smiles": "CC1=NC(N[C@@H](C2=CC(C(F)(F)F)=CC(N)=C2)C)=C3C=C(O[C@@H]4COCC4)C(OC)=CC3=N1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 16.0,
        "IC50": 15.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 84.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 100.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 1,
      "paper_title": "Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design",
      "paper_author": [
        "Long Chen",
        "Chunlin Zhuang",
        "Junjie Lu",
        "Yan Jiang",
        "Chunquan Sheng"
      ],
      "paper_year": 2018,
      "paper_institution": "Second Military Medical University",
      "paper_cited": 10,
      "doi": "10.1021/acs.jmedchem.8b00057",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-6/acs.jmedchem.8b00057/20180315/images/large/jm-2018-00057c_0010.jpeg",
      "compound_count": 36,
      "compound_name": "11b",
      "compound_name_drug": "",
      "compound_smiles": "c1cnccc1Cn1c2c(nc1c1ccc(OCCN3C(c4c(F)cccc4)Nc4c(cccc4)C3=O)cc1)cccc2",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 38.0,
        "IC50": 880.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 2,
      "paper_title": "RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation",
      "paper_author": [
        "Giulia Miglietta",
        "Susanna Cogoi",
        "Jessica Marinello",
        "Giovanni Capranico",
        "Alexander S. Tikhomirov",
        "Andrey Shchekotikhin",
        "Luigi E. Xodo"
      ],
      "paper_year": 2017,
      "paper_institution": "Department of Medicine, Biochemistry Laboratory, University of Udine, 33100 Udine, Italy",
      "paper_cited": 38,
      "doi": "10.1021/acs.jmedchem.7b00622",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00622/20171215/images/large/jm-2017-006225_0012.jpeg",
      "compound_count": 10,
      "compound_name": "2a",
      "compound_name_drug": "",
      "compound_smiles": "C(CCCCCCCCC1CC(Cc2ccc(*)cc2)C1)*",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 75.0,
        "IC50": 260.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 3,
      "paper_title": "Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer",
      "paper_author": [
        "Junfei Cheng",
        "Yu Li",
        "Xu Wang",
        "Guoqiang Dong",
        "Chunquan Sheng"
      ],
      "paper_year": 2020,
      "paper_institution": "Second Military Medical University",
      "paper_cited": 6,
      "doi": "10.1021/acs.jmedchem.0c00929",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00929/20200716/images/large/jm0c00929_0012.jpeg",
      "compound_count": 29,
      "compound_name": "17f",
      "compound_name_drug": "",
      "compound_smiles": "O=C1C(N2C(=O)c3cccc(NCCCCCCCCNC(=O)CCCn4c(=O)c5c(c(n4)C)c(C)n(n5)c4ccc(C)cc4)c3C2=O)CCC(=O)N1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 9.0,
        "IC50": 8000.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 8000.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 4710.0,
        "solubility": 0.0,
        "t_half": 5.1,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 4,
      "paper_title": "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3H)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor",
      "paper_author": [
        "Malcolm P. Huestis",
        "Darlene Dela Cruz",
        "Antonio G. DiPasquale",
        "Matthew R. Durk",
        "Charles Eigenbrot",
        "Paul Gibbons",
        "Alberto Gobbi",
        "Thomas L. Hunsaker",
        "Hank La",
        "Dennis H. Leung",
        "Wendy Liu",
        "Shiva Malek",
        "Mark Merchant",
        "John G. Moffat",
        "Christine S. Muli",
        "Christine J. Orr",
        "Brendan T. Parr",
        "Frances Shanahan",
        "Christopher J. Sneeringer",
        "Weiru Wang",
        "Ivana Yen",
        "Jianping Yin",
        "Michael Siu",
        "Joachim Rudolph"
      ],
      "paper_year": 2021,
      "paper_institution": "Small Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States",
      "paper_cited": 1,
      "doi": "10.1021/acs.jmedchem.0c02085",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02085/20210331/images/large/jm0c02085_0013.jpeg",
      "compound_count": 23,
      "compound_name": "7",
      "compound_name_drug": "",
      "compound_smiles": "FC(C=C1C)=C(NC(NCCC(C)(C)C)=O)C=C1NC2=CC=C(N=CN(C)C3=O)C3=C2F",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.08,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 5,
      "paper_title": "Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer",
      "paper_author": [
        "Jay B. Fell",
        "John P. Fischer",
        "Brian R. Baer",
        "James F. Blake",
        "Karyn Bouhana",
        "David M. Briere",
        "Karin D. Brown",
        "Laurence E. Burgess",
        "Aaron C. Burns",
        "Michael R. Burkard",
        "Harrah Chiang",
        "Mark J. Chicarelli",
        "Adam W. Cook",
        "John J. Gaudino",
        "Jill Hallin",
        "Lauren Hanson",
        "Dylan P. Hartley",
        "Erik J. Hicken",
        "Gary P. Hingorani",
        "Ronald J. Hinklin",
        "Macedonio J. Mejia",
        "Peter Olson",
        "Jennifer N. Otten",
        "Susan P. Rhodes",
        "Martha E. Rodriguez",
        "Pavel Savechenkov",
        "Darin J. Smith",
        "Niranjan Sudhakar",
        "Francis X. Sullivan",
        "Tony P. Tang",
        "Guy P. Vigers",
        "Lance Wollenberg",
        "James G. Christensen",
        "Matthew A. Marx"
      ],
      "paper_year": 2020,
      "paper_institution": "Array BioPharma Inc, 3200 Walnut Street, Boulder, Colorado 80301, United States",
      "paper_cited": 50,
      "doi": "10.1021/acs.jmedchem.9b02052",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.9b02052/20200701/images/large/jm9b02052_0033.jpeg",
      "compound_count": 40,
      "compound_name": "MRTX849",
      "compound_name_drug": "MRTX849",
      "compound_smiles": "c1c2cccc(N3CCc4c(nc(nc4N4C[C@@H](N(CC4)C(=O)C(=C)F)CC#N)OC[C@H]4N(CCC4)C)C3)c2c(Cl)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 3700.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 20.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 15.9,
        "solubility": 0.0,
        "t_half": 50.0,
        "bioavailability": 62.9
      },
      "clinical_statistics": {
        "p1_company_num": 2,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 0, 2, 0, 0],
        "p1_company": [
          [],
          [],
          [],
          [],
          [],
          [],
          ["Mirati Therapeutics", "Mirati Therapeutics Inc."],
          [],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 2,
        "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 2, 0, 0],
        "p2_company": [
          [],
          [],
          [],
          [],
          [],
          [],
          ["Mirati Therapeutics", "Mirati Therapeutics Inc."],
          [],
          []
        ],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 2,
        "p3_stat_company_num": [0, 2, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [
          [],
          ["Mirati Therapeutics", "Mirati Therapeutics Inc."],
          [],
          [],
          [],
          [],
          [],
          [],
          []
        ],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 6,
      "paper_title": "Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C",
      "paper_author": [
        "Jason G. Kettle",
        "Sharan K. Bagal",
        "Sue Bickerton",
        "Michael S. Bodnarchuk",
        "Jason Breed",
        "Rodrigo J. Carbajo",
        "Doyle J. Cassar",
        "Atanu Chakraborty",
        "Sabina Cosulich",
        "Iain Cumming",
        "Michael Davies",
        "Andrew Eatherton",
        "Laura Evans",
        "Lyman Feron",
        "Shaun Fillery",
        "Emma S. Gleave",
        "Frederick W. Goldberg",
        "Stephanie Harlfinger",
        "Lyndsey Hanson",
        "Martin Howard",
        "Rachel Howells",
        "Anne Jackson",
        "Paul Kemmitt",
        "Jennifer K. Kingston",
        "Scott Lamont",
        "Hilary J. Lewis",
        "Songlei Li",
        "Libin Liu",
        "Derek Ogg",
        "Christopher Phillips",
        "Radek Polanski",
        "Graeme Robb",
        "David Robinson",
        "Sarah Ross",
        "James M. Smith",
        "Michael Tonge",
        "Rebecca Whiteley",
        "Junsheng Yang",
        "Longfei Zhang",
        "Xiliang Zhao"
      ],
      "paper_year": 2020,
      "paper_institution": "Oncology R&D, AstraZeneca, Cambridge CB4 0WG, U.K.",
      "paper_cited": 11,
      "doi": "10.1021/acs.jmedchem.9b01720",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-9/acs.jmedchem.9b01720/20200507/images/large/jm9b01720_0016.jpeg",
      "compound_count": 44,
      "compound_name": "25",
      "compound_name_drug": "",
      "compound_smiles": "c1cc(c(c2c(Cl)cc3c4N5[C@@H](C(=O)N(c4cnc3c2F)C)CN(C(=C)C5)C(=O)C=C)c(F)c1)O",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 5.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 628.5,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 94.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 7,
      "paper_title": "Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers",
      "paper_author": [
        "Gisele A. Nishiguchi",
        "Alice Rico",
        "Huw Tanner",
        "Robert J. Aversa",
        "Benjamin R. Taft",
        "Sharadha Subramanian",
        "Lina Setti",
        "Matthew T. Burger",
        "Lifeng Wan",
        "Victoriano Tamez",
        "Aaron Smith",
        "Yan Lou",
        "Paul A. Barsanti",
        "Brent A. Appleton",
        "Mulugeta Mamo",
        "Laura Tandeske",
        "Ina Dix",
        "John E. Tellew",
        "Shenlin Huang",
        "Lesley A. Mathews Griner",
        "Vesselina G. Cooke",
        "Anne Van Abbema",
        "Hanne Merritt",
        "Sylvia Ma",
        "Kalyani Gampa",
        "Fei Feng",
        "Jing Yuan",
        "Yingyun Wang",
        "Jacob R. Haling",
        "Sepideh Vaziri",
        "Mohammad Hekmat-Nejad",
        "Johanna M. Jansen",
        "Valery Polyakov",
        "Richard Zang",
        "Vijay Sethuraman",
        "Payman Amiri",
        "Mallika Singh",
        "Emma Lees",
        "Wenlin Shao",
        "Darrin D. Stuart",
        "Michael P. Dillon",
        "Savithri Ramurthy"
      ],
      "paper_year": 2017,
      "paper_institution": "Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States",
      "paper_cited": 21,
      "doi": "10.1021/acs.jmedchem.6b01862",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.6b01862/20170616/images/large/jm-2016-01862v_0017.jpeg",
      "compound_count": 30,
      "compound_name": "14",
      "compound_name_drug": "",
      "compound_smiles": "Cc1ncc(cc1c3cnc(OC2CCOCC2)c(c3)N4CCOCC4)NC(=O)c5cccc(c5)C(F)(F)F",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.4,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 21.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 120000.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 1.0,
        "solubility": 0.0,
        "t_half": 6.5,
        "bioavailability": 48.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 8,
      "paper_title": "Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells",
      "paper_author": [
        "James R. Henry",
        "Michael D. Kaufman",
        "Sheng-Bin Peng",
        "Yu Mi Ahn",
        "Timothy M. Caldwell",
        "Lakshminarayana Vogeti",
        "Hanumaiah Telikepalli",
        "Wei-Ping Lu",
        "Molly M. Hood",
        "Thomas J. Rutkoski",
        "Bryan D. Smith",
        "Subha Vogeti",
        "David Miller",
        "Scott C. Wise",
        "Lawrence Chun",
        "Xiaoyi Zhang",
        "Youyan Zhang",
        "Lisa Kays",
        "Philip A. Hipskind",
        "Aaron D. Wrobleski",
        "Karen L. Lobb",
        "Julia M. Clay",
        "Jeffrey D. Cohen",
        "Jennie L. Walgren",
        "Denis McCann",
        "Phenil Patel",
        "David K. Clawson",
        "Sherry Guo",
        "Danalyn Manglicmot",
        "Chris Groshong",
        "Cheyenne Logan",
        "James J. Starling",
        "Daniel L. Flynn"
      ],
      "paper_year": 2015,
      "paper_institution": "Eli Lilly and Company, Indianapolis, Indiana 46285, United States",
      "paper_cited": 50,
      "doi": "10.1021/acs.jmedchem.5b00067",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00067/20150521/images/large/jm-2015-000678_0016.jpeg",
      "compound_count": 43,
      "compound_name": "13",
      "compound_name_drug": "LY3009120",
      "compound_smiles": "CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 5.8,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 44.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 169.0,
        "solubility": 0.0,
        "t_half": 1.4,
        "bioavailability": 3.6
      },
      "clinical_statistics": {
        "p1_company_num": 1,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 1, 0, 0, 0],
        "p1_company": [
          [],
          [],
          [],
          [],
          [],
          ["Eli Lilly and Company"],
          [],
          [],
          []
        ],
        "p1_terminate_reason": {
          "Eli Lilly and Company": "Progressive Disease"
        },
        "p1_withdraw_reason": {},
        "p1_adverse_event": { "Eli Lilly and Company": 0.0 },
        "p2_company_num": 0,
        "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p2_company": [[], [], [], [], [], [], [], [], []],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 0,
        "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0],
        "p3_company": [[], [], [], [], [], [], [], [], []],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 9,
      "paper_title": "Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors",
      "paper_author": [
        "Brian A. Lanman",
        "Jennifer R. Allen",
        "John G. Allen",
        "Albert K. Amegadzie",
        "Kate S. Ashton",
        "Shon K. Booker",
        "Jian Jeffrey Chen",
        "Ning Chen",
        "Michael J. Frohn",
        "Guy Goodman",
        "David J. Kopecky",
        "Longbin Liu",
        "Patricia Lopez",
        "Jonathan D. Low",
        "Vu Ma",
        "Ana E. Minatti",
        "Thomas T. Nguyen",
        "Nobuko Nishimura",
        "Alexander J. Pickrell",
        "Anthony B. Reed",
        "Youngsook Shin",
        "Aaron C. Siegmund",
        "Nuria A. Tamayo",
        "Christopher M. Tegley",
        "Mary C. Walton",
        "Hui-Ling Wang",
        "Ryan P. Wurz",
        "May Xue",
        "Kevin C. Yang",
        "Pragathi Achanta",
        "Michael D. Bartberger",
        "Jude Canon",
        "L. Steven Hollis",
        "John D. McCarter",
        "Christopher Mohr",
        "Karen Rex",
        "Anne Y. Saiki",
        "Tisha San Miguel",
        "Laurie P. Volak",
        "Kevin H. Wang",
        "Douglas A. Whittington",
        "Stephan G. Zech",
        "J. Russell Lipford",
        "Victor J. Cee"
      ],
      "paper_year": 2019,
      "paper_institution": "Departments of Medicinal Chemistry, and, Amgen Research, One Amgen Center Drive",
      "paper_cited": 69,
      "doi": "10.1021/acs.jmedchem.9b01180",
      "paper_journal": "Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-1/acs.jmedchem.9b01180/20200106/images/large/jm9b01180_0017.jpeg",
      "compound_count": 36,
      "compound_name": "38",
      "compound_name_drug": "AMG 510",
      "compound_smiles": "C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 68.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 423.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.5,
        "bioavailability": 28.0
      },
      "clinical_statistics": {
        "p1_company_num": 2,
        "p1_stat_company_num": [0, 0, 0, 0, 0, 0, 2, 0, 0],
        "p1_company": [
          [],
          [],
          [],
          [],
          [],
          [],
          ["Southwest Oncology Group", "Amgen"],
          [],
          []
        ],
        "p1_terminate_reason": {},
        "p1_withdraw_reason": {},
        "p1_adverse_event": {},
        "p2_company_num": 2,
        "p2_stat_company_num": [1, 0, 0, 0, 0, 0, 1, 0, 0],
        "p2_company": [
          ["Southwest Oncology Group"],
          [],
          [],
          [],
          [],
          [],
          ["Amgen"],
          [],
          []
        ],
        "p2_terminate_reason": {},
        "p2_withdraw_reason": {},
        "p2_adverse_event": {},
        "p3_company_num": 1,
        "p3_stat_company_num": [0, 0, 0, 1, 0, 0, 0, 0, 0],
        "p3_company": [[], [], [], ["Amgen"], [], [], [], [], []],
        "p3_terminate_reason": {},
        "p3_withdraw_reason": {},
        "p3_adverse_event": {}
      }
    },
    {
      "id": 10,
      "paper_title": "Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors",
      "paper_author": [
        "Pingyuan Wang",
        "Dharini van der Hoeven",
        "Na Ye",
        "Haiying Chen",
        "Zhiqing Liu",
        "Xiaoping Ma",
        "Dina Montufar-Solis",
        "Kristen M. Rehl",
        "Kwang-Jin Cho",
        "Sabita Thapa",
        "Wei Chen",
        "Ransome van der Hoeven",
        "Jeffrey A. Frost",
        "John F. Hancock",
        "Jia Zhou"
      ],
      "paper_year": 2021,
      "paper_institution": "Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, USA",
      "paper_cited": 0,
      "doi": "10.1016/j.ejmech.2021.113381",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002300-ga1_lrg.jpg",
      "compound_count": 67,
      "compound_name": "12f",
      "compound_name_drug": "",
      "compound_smiles": "C1N(CCC1)CCN([C@@H](c1ccc(OC)cc1)C)CC=C(c1ccccc1)c1ccccc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 300.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 11,
      "paper_title": "Design, synthesis and pharmacological evaluation of bicyclic and tetracyclic pyridopyrimidinone analogues as new KRASG12C inhibitors",
      "paper_author": [
        "Xuanzheng Xiao",
        "Mengzhen Lai",
        "Zilan Song",
        "Meiyu Geng",
        "Jian Ding",
        "Hua Xie",
        "Ao Zhang"
      ],
      "paper_year": 2021,
      "paper_institution": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China",
      "paper_cited": 0,
      "doi": "10.1016/j.ejmech.2020.113082",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420310540-fx1_lrg.jpg",
      "compound_count": 90,
      "compound_name": "26a",
      "compound_name_drug": "",
      "compound_smiles": "c1cc(c(c2c(Cl)cc3c4N5[C@@H](C(=O)N(c4cnc3c2F)C)CN(C(=C)C5)C(=O)C=C)c(F)c1)O",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 1870.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 790.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 12,
      "paper_title": "Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties",
      "paper_author": [
        "A. Sergi Capilla",
        "Richard Soucek",
        "Laura Grau",
        "Manel Romero",
        "Jaime Rubio-Martínez",
        "Daniel H. Caignard",
        "Maria Dolors Pujol"
      ],
      "paper_year": 2018,
      "paper_institution": "Laboratori de Química Farmacèutica (Unitat associada al CSIC), Facultat de Farmàcia, Universitat de Barcelona, Spain",
      "paper_cited": 9,
      "doi": "10.1016/j.ejmech.2017.12.098",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417311297-fx1_lrg.jpg",
      "compound_count": 35,
      "compound_name": "12",
      "compound_name_drug": "",
      "compound_smiles": "COc1cc2CCNC(c3cc(OC)c(OC)c(OC)c3)c2cc1OC",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 2600.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 2600.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 13,
      "paper_title": "Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors",
      "paper_author": [
        "Seok Jong Kang",
        "Jung Wuk Lee",
        "Shin Hyuck Chung",
        "Sun Young Jang",
        "Jaeyul Choi",
        "Kwee Hyun Suh",
        "Young Hoon Kim",
        "Young Jin Ham",
        "Kyung Hoon Min"
      ],
      "paper_year": 2019,
      "paper_institution": "College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea",
      "paper_cited": 2,
      "doi": "10.1016/j.ejmech.2018.12.025",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418310626-fx1_lrg.jpg",
      "compound_count": 37,
      "compound_name": "22a",
      "compound_name_drug": "",
      "compound_smiles": "N(C1CC1)c1c2nccn2c(cn1)c1c(C)cc(NC(=O)Nc2n(nc(C(C)(C)C)c2)c2ccccc2)cc1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 37.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 274.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 50000.0,
        "solubility": 25.2
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 3144.0,
        "solubility": 0.0,
        "t_half": 1.6,
        "bioavailability": 0.0
      },
      "clinical_statistics": {}
    },
    {
      "id": 14,
      "paper_title": "Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design",
      "paper_author": [
        "Dezhong Ji",
        "Lingzhi Zhang",
        "Qihua Zhu",
        "Ying Bai",
        "Yaoyao Wu",
        "Yungen Xu"
      ],
      "paper_year": 2019,
      "paper_institution": "Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China",
      "paper_cited": 3,
      "doi": "10.1016/j.ejmech.2018.12.040",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418310778-fx1_lrg.jpg",
      "compound_count": 57,
      "compound_name": "22a",
      "compound_name_drug": "",
      "compound_smiles": "C(C=C)c1cc(CN2CCC(N)CC2)c(O)c(c2cc(CC=C)ccc2O)c1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 1.5,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 193.53,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 8380.0,
        "solubility": 0.0,
        "t_half": 3.6,
        "bioavailability": 22.5
      },
      "clinical_statistics": {}
    },
    {
      "id": 15,
      "paper_title": "Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer",
      "paper_author": [
        "Huan Tang",
        "Yongguang Zhang",
        "Dan Li",
        "Suhong Fu",
        "Minghai Tang",
        "Li Wan",
        "Kai Chen",
        "Zhuowei Liu",
        "Linlin Xue",
        "Aihua Peng",
        "Haoyu Ye",
        "Lijuan Chen"
      ],
      "paper_year": 2018,
      "paper_institution": "State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China",
      "paper_cited": 15,
      "doi": "10.1016/j.ejmech.2018.06.048",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418305397-fx1_lrg.jpg",
      "compound_count": 36,
      "compound_name": "C2",
      "compound_name_drug": "",
      "compound_smiles": "C(C=C)c1cc(CN2CCC(N)CC2)c(O)c(c2cc(CC=C)ccc2O)c1",
      "medicinal_chemistry_metrics": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 5010.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 5480.0,
        "IC50": 0.0,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 10000.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 0.0,
        "bioavailability": 0.0
      },
      "clinical_statistics": {
        "p1_company_num": 262,
        "p1_stat_company_num": [3, 18, 0, 7, 1, 6, 225, 0, 2],
        "p1_company": [
          [
            "Meabco A/S",
            "Aptevo Therapeutics",
            "Center of Excellence in Vaccine Research and Development, Faculty of Medicine, Chulalongkorn University"
          ],
          [
            "Peking University Third Hospital",
            "National University Hospital, Singapore",
            "Centre Leon Berard",
            "AIDS Malignancy Consortium",
            "Nektar Therapeutics",
            "CSL Behring",
            "Statens Serum Institut",
            "LEO Pharma",
            "Janssen Research & Development, LLC",
            "Tufts Medical Center",
            "MacroGenics",
            "Dicerna Pharmaceuticals",
            "City of Hope Comprehensive Cancer Center LAO",
            "The University of Michigan Rogel Cancer Center",
            "Canadian Center for Vaccinology",
            "Celgene/BMS",
            "Arizona Research Center",
            "James R. Urbaniak, MD, Duke Sports Science Institute"
          ],
          [],
          [
            "EMD Serono Research & Development Institute, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany",
            "University of California",
            "Weill Medical College of Cornell University",
            "City of Hope Comprehensive Cancer Center",
            "IOSI -Ospedale San Giovanni, Bellinzona",
            "Ohio State University",
            "University of California, Davis"
          ],
          ["Dartmouth-Hitchcock Norris Cotton Cancer Centre"],
          [
            "Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center",
            "Georgetown Lombardi Comprehsnive Cancer Center",
            "Karmanos Cancer Institute Hudson-Webber Cancer Research Center",
            "Idorsia Pharmaceuticals Ltd.",
            "Merck KGaA, Darmstadt, Germany",
            "Grünenthal GmbH"
          ],
          [
            "Fondazione EMN Italy Onlus",
            "Highlight Therapeutics",
            "Center for Human Drug Research (The Netherlands)",
            "Haukeland University Hospital, Department of Heart Disease",
            "AstraZeneca Pharmaceuticals;C2C-716 1800 Concord PikePO. Box 15437Wilmington De 19850-5437",
            "Northern Jiangsu Province People's Hospital",
            "Merck Sharp & Dohme Corp.",
            "University of California, San Francisco",
            "Cambridge University Hospitals",
            "St. Jude Children's Research Hospital",
            "Takeda",
            "Hospital Universitario Central de Asturias",
            "Montefiore Medical Center",
            "Laser Center",
            "Indiana University Melvin and Bren Simon Cancer Center",
            "fondazione IRCCS istituto nazionale tumori Milano",
            "University of Oxford",
            "Princess Margaret Hospital, Canada",
            "Vanderbilt University Medical Center",
            "Fox Chase Cancer Center",
            "University of the Witswatersrand",
            "Institut National de la Santé Et de la Recherche Médicale, France",
            "Rady Children's Hospital",
            "Hôpital Européen Georges Pompidou, Oncology Department",
            "New York Presbyterian Hospital, New York, NY 10021, United States",
            "C4Pain",
            "University of Arizona",
            "AstraZeneca R&D SödertäljeMedical Science, CPU C2:84Karolinska University Hospital HuddingeSE-141 86 Stockholm, Sweden",
            "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA",
            "Weill Medical College of Cornell University, New York Hospital Department of Neurology",
            "Tel-Aviv Sourasky Medical Center",
            "Yale University",
            "Justus-Liebig University of Giessen",
            "Mayo Clinic",
            "Attending Physician, Emergency Department",
            "AMES Technology Inc./ Oregon Health and Science University",
            "Ottawa Hospital Research Institute",
            "AstraZeneca",
            "Mary Crowley Cancer Research Centers",
            "New York Medical College",
            "BioNTech SE",
            "University of Michigan",
            "University of Chicago",
            "Centre d'Oncologie de Gentilly - Nancy - France",
            "Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium",
            "Case Comprehensive Cancer Center",
            "McMaster University Hospital",
            "The University of Chicago Medical Center",
            "Asklepios fachkliniken München-Gauting",
            "Oregon Health and Science University",
            "Wave Life Sciences",
            "Vastra Gotaland Region",
            "Alliance Foundation Trials, LLC.",
            "Amphastar Pharmaceuticals, Inc.",
            "AstraZeneca R&D, Mölndal, Sweden",
            "Puma Biotechnology, Inc.",
            "AIDS Associated Malignancies Clinical Trials Consortium",
            "University of Pittsburgh",
            "Department of Hematology, S. Orsola-Malpighi University of Bologna",
            "Services des maladies infectieuses et tropicales, Hopital de la Pitié-Salpétrière, Université Pierre et Marie Curie, INSERM U720",
            "CPC Clinical Research",
            "Bayer",
            "Children's Oncology Group",
            "Institute of Tropical Medicine, University of Tuebingen, Wilhelmstr. 27, Germany",
            "Hadassah Medical Center, Ein Kerem, Jerusalem",
            "University of Vermont",
            "Assistance Publique -hôpitaux de Marseille",
            "University Hospital, Toulouse",
            "Medical College of Wisconsin",
            "University of South Florida",
            "Mayo Clinic in Minnesota",
            "Clinical Neuroscience TA AstraZeneca R&D Södertälje, Sweden",
            "Lymphoma Study Association",
            "Inamed Research GmbH & Co. KG",
            "Cancer Therapy & Research Center University of Texas Health Science Center San Antonio",
            "Eastern Cooperative Oncology Group",
            "Rigshospitalet, Denmark",
            "Stephenson Cancer Center, University of Oklahoma Health Sciences Center",
            "Nuvisan GmbH",
            "Angion Biomedica",
            "Washington University School of Medicine",
            "Tennessee Oncology / Sarah Cannon",
            "Peking University Peoples Hospital",
            "Centre Hospitalier Intercommunal Créteil",
            "Fred Hutch/University of Washington Cancer Consortium",
            "Velindre NHS Trust",
            "Assisted Conception Unit",
            "Ipsen",
            "Centre du Cancer, Cliniques universitaires Saint-Luc",
            "UC San Diego, Division of Blood and Marrow Transplantation",
            "Millennium Pharmaceuticals, Inc.",
            "Novo Nordisk A/S",
            "Toronto Sunnybrook Regional Cancer Centre",
            "Rutgers Cancer Institute of New Jersey",
            "Ohio State University Comprehensive Cancer Center",
            "Enteric Diseases Department, Naval Medical Research Center",
            "NYU Langone Medical Center",
            "University Hospital of Grenoble, Department of Endocrinology",
            "Texas Heart Institute",
            "Sponsor GmbH",
            "Covance CRU",
            "Samsung Medical Center",
            "CRLC Val d'Aurelle-Paul Lamarque",
            "UCSF Memory and Aging Center",
            "University Hospital Tuebingen",
            "Ministry of Public Health, Argentina",
            "Korea",
            "Hull University Teaching Hospitals NHS Trust",
            "Wake Forest University Health Sciences",
            "Genentech, Inc.",
            "Anaheim Clinical Trials",
            "University of California, San Diego",
            "Lung and Allergy Clinic, Karolinska UH",
            "Bristol-Myers Squibb",
            "BeiGene",
            "CUHK",
            "Alliance for Clinical Trials in Oncology",
            "Fudan University",
            "Radius Health, Inc.",
            "Huashan Hospital, Fundan University",
            "Hoffmann-La Roche",
            "Quotient Sciences",
            "Roswell Park Cancer Institute",
            "PALG",
            "Abbott",
            "Rockefeller University",
            "AbbVie",
            "Sanofi",
            "Pfizer",
            "OHSU Knight Cancer Institute",
            "ECOG-ACRIN Cancer Research Group",
            "Sun Yat-sen Memorial Hospital,Sun Yat-sen University",
            "City of Hope Medical Center",
            "VA Medical Center, Bronx",
            "Novartis Pharmaceuticals",
            "Hospital Universitario 12 De Octubre,Madrid, Spain",
            "Robert H. Lurie Cancer Center",
            "Centre Antoine Lacassagne",
            "Tri-Service General Hospital",
            "Syndax Pharmaceuticals",
            "M.D. Anderson Cancer Center",
            "Hospital Ambroise Paré Paris",
            "Southwest Oncology Group",
            "Abbott Medical Devices",
            "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center",
            "AlphaVax, Inc.",
            "Department of Neurology, Tel Aviv Sourasky Medical Center",
            "Janssen Vaccines & Prevention B.V.",
            "National Cancer Institute (NCI)",
            "Hoosier Cancer Research Network",
            "National Institute of Allergy and Infectious Diseases (NIAID)",
            "UC Davis Comprehensive Cancer Center",
            "Klinik Hirslanden, Zurich",
            "Actelion",
            "CHU de Brest",
            "Cardiovascular Imaging Technologies",
            "Arthritis Program, Toronto Western Hospital",
            "Alkermes, Inc.",
            "Eli Lilly and Company",
            "Beth Israel Deaconess Medical Center",
            "HUYA Bioscience International, LLC",
            "SOLTI Breast Cancer Research Group",
            "HemoShear Therapeutics, Inc.",
            "OliX Pharmaceuticals",
            "Immunocore Ltd",
            "GlaxoSmithKline",
            "Erasme hospital",
            "Hôpital Cochin, Paris",
            "Tokyo University",
            "Boehringer Ingelheim",
            "University Hospital Aachen - Germany",
            "Memorial Sloan Kettering Cancer Center",
            "University of Maryland Greenebaum Cancer Center",
            "ICON Early Phase Services, LLC",
            "University of Nebraska",
            "University Hospital, Geneva",
            "Academic and Community Cancer Research United",
            "Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany",
            "Cephalon",
            "Aurum Institute for Health Research",
            "Cliniques universitaires Saint-Luc",
            "University Hospital Innsbruck, Austria",
            "Cancer and Leukemia Group B",
            "Xuanwu Hospital, Beijing",
            "Texas Heart Institute/St. Luke's Hospital",
            "Pierre Fabre Medicament",
            "University of Miami Sylvester Comprehensive Cancer Center",
            "Director CES-LPH Research Group",
            "yzhai@ascentagepharma.com",
            "Stanford University",
            "Academic Medical Centre (Amsterdam)",
            "UroGen Pharma",
            "Hadassah Medical Center",
            "Thomas Jefferson University",
            "North Central Cancer Treatment Group",
            "Nucleus Network",
            "Ambrilia Biopharma, Inc.",
            "Med. Klinik V, University Hospital Heidelberg",
            "National Cancer Center",
            "Northwestern University",
            "National Taiwan University Hospital",
            "Impel NeuroPharma, Seattle, WA (USA)",
            "University of Washington",
            "Fuda Cancer Hospital, Guangzhou",
            "Henry Ford Health System",
            "Nationwide Children's Hospital",
            "Mayo Clinic in Rochester",
            "Dana-Farber Cancer Institute",
            "Viracta Therapeutics",
            "French Innovative Leukemia Organisation",
            "Alicante General University Hospital",
            "Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni",
            "Butantan Institute",
            "Biogen",
            "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
            "Radiant Research",
            "Beijing Ditan Hospital",
            "Barbara Ann Karmanos Institute",
            "Hospitales Universitarios Virgen del Rocío",
            "CHU de Nantes",
            "University Hospital, Lille",
            "Assistance Publique - Hôpitaux de Paris",
            "Department of HPH Surgery, National Liver Institute, University of Menoufia, Egypt",
            "Peking University First Hospital",
            "Regeneron Pharmaceuticals"
          ],
          [],
          [
            "Cancer Hosptial, Chinese Academy of Medical Sciences",
            "Dong-A University Hospital"
          ]
        ],
        "p1_terminate_reason": {
          "University of California, San Francisco": "Screen B Ineligible (Page 55, Protocol)"
        },
        "p1_withdraw_reason": {},
        "p1_adverse_event": {
          "Pfizer": 0.5,
          "Merck KGaA, Darmstadt, Germany": 0.0,
          "Eli Lilly and Company": 0.0,
          "Genentech, Inc.": 0.4482758620689655,
          "University of California, San Francisco": 0.6666666666666666
        },
        "p2_company_num": 193,
        "p2_stat_company_num": [7, 33, 0, 15, 0, 17, 112, 4, 5],
        "p2_company": [
          [
            "Lymphoma Study Association",
            "University of Vermont",
            "Hospital Universitario 12 De Octubre,Madrid, Spain",
            "Yale University",
            "Ministry of Public Health, Argentina",
            "McMaster University Hospital",
            "Academic and Community Cancer Research United"
          ],
          [
            "University Hospital, Toulouse",
            "Highlight Therapeutics",
            "Cambridge University Hospitals",
            "St. Jude Children's Research Hospital",
            "yzhai@ascentagepharma.com",
            "Cancer Therapy & Research Center University of Texas Health Science Center San Antonio",
            "National Cancer Institute (NCI)",
            "Fox Chase Cancer Center",
            "Fred Hutch/University of Washington Cancer Consortium",
            "UC Davis Comprehensive Cancer Center",
            "Millennium Pharmaceuticals, Inc.",
            "Ohio State University Comprehensive Cancer Center",
            "National Cancer Center",
            "Northwestern University",
            "Ottawa Hospital Research Institute",
            "University Hospital Tuebingen",
            "Beth Israel Deaconess Medical Center",
            "SOLTI Breast Cancer Research Group",
            "HemoShear Therapeutics, Inc.",
            "OliX Pharmaceuticals",
            "Viracta Therapeutics",
            "Wake Forest University Health Sciences",
            "BioNTech SE",
            "Butantan Institute",
            "University of Chicago",
            "Memorial Sloan Kettering Cancer Center",
            "Wave Life Sciences",
            "Vastra Gotaland Region",
            "University Hospital, Geneva",
            "Barbara Ann Karmanos Institute",
            "OHSU Knight Cancer Institute",
            "Assistance Publique -hôpitaux de Marseille",
            "ECOG-ACRIN Cancer Research Group"
          ],
          [],
          [
            "Stephenson Cancer Center, University of Oklahoma Health Sciences Center",
            "Janssen Vaccines & Prevention B.V.",
            "Medical College of Wisconsin",
            "Hoosier Cancer Research Network",
            "Washington University School of Medicine",
            "HUYA Bioscience International, LLC",
            "Robert H. Lurie Cancer Center",
            "Roswell Park Cancer Institute",
            "Immunocore Ltd",
            "Merck Sharp & Dohme Corp.",
            "Department of Hematology, S. Orsola-Malpighi University of Bologna",
            "University of California, San Francisco",
            "UC San Diego, Division of Blood and Marrow Transplantation",
            "CHU de Nantes",
            "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center"
          ],
          [],
          [
            "Indiana University Melvin and Bren Simon Cancer Center",
            "Hadassah Medical Center",
            "Biogen",
            "University of Washington",
            "Asklepios fachkliniken München-Gauting",
            "Mary Crowley Cancer Research Centers",
            "Mayo Clinic in Minnesota",
            "University Hospital Innsbruck, Austria",
            "Cliniques universitaires Saint-Luc",
            "Assisted Conception Unit",
            "Ipsen",
            "Centre du Cancer, Cliniques universitaires Saint-Luc",
            "Lung and Allergy Clinic, Karolinska UH",
            "University Hospital, Lille",
            "University Hospital of Grenoble, Department of Endocrinology",
            "Tel-Aviv Sourasky Medical Center",
            "Case Comprehensive Cancer Center"
          ],
          [
            "Fondazione EMN Italy Onlus",
            "Haukeland University Hospital, Department of Heart Disease",
            "Northern Jiangsu Province People's Hospital",
            "Hospital Universitario Central de Asturias",
            "Montefiore Medical Center",
            "Laser Center",
            "fondazione IRCCS istituto nazionale tumori Milano",
            "University of Oxford",
            "Princess Margaret Hospital, Canada",
            "Vanderbilt University Medical Center",
            "Rady Children's Hospital",
            "C4Pain",
            "University of Arizona",
            "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA",
            "Weill Medical College of Cornell University, New York Hospital Department of Neurology",
            "Justus-Liebig University of Giessen",
            "Mayo Clinic",
            "Attending Physician, Emergency Department",
            "AMES Technology Inc./ Oregon Health and Science University",
            "University of Michigan",
            "Centre d'Oncologie de Gentilly - Nancy - France",
            "The University of Chicago Medical Center",
            "Oregon Health and Science University",
            "Alliance Foundation Trials, LLC.",
            "Amphastar Pharmaceuticals, Inc.",
            "AstraZeneca R&D, Mölndal, Sweden",
            "Puma Biotechnology, Inc.",
            "AIDS Associated Malignancies Clinical Trials Consortium",
            "University of Pittsburgh",
            "Services des maladies infectieuses et tropicales, Hopital de la Pitié-Salpétrière, Université Pierre et Marie Curie, INSERM U720",
            "CPC Clinical Research",
            "Children's Oncology Group",
            "Inamed Research GmbH & Co. KG",
            "Eastern Cooperative Oncology Group",
            "Rigshospitalet, Denmark",
            "Peking University Peoples Hospital",
            "Centre Hospitalier Intercommunal Créteil",
            "Velindre NHS Trust",
            "Toronto Sunnybrook Regional Cancer Centre",
            "Texas Heart Institute",
            "Sponsor GmbH",
            "Samsung Medical Center",
            "CRLC Val d'Aurelle-Paul Lamarque",
            "Hull University Teaching Hospitals NHS Trust",
            "University of California, San Diego",
            "BeiGene",
            "Bristol-Myers Squibb",
            "CUHK",
            "Alliance for Clinical Trials in Oncology",
            "Fudan University",
            "Radius Health, Inc.",
            "Hoffmann-La Roche",
            "PALG",
            "Abbott",
            "Rockefeller University",
            "AbbVie",
            "Sanofi",
            "Pfizer",
            "Sun Yat-sen Memorial Hospital,Sun Yat-sen University",
            "City of Hope Medical Center",
            "VA Medical Center, Bronx",
            "Novartis Pharmaceuticals",
            "Centre Antoine Lacassagne",
            "M.D. Anderson Cancer Center",
            "Hospital Ambroise Paré Paris",
            "Southwest Oncology Group",
            "AlphaVax, Inc.",
            "Department of Neurology, Tel Aviv Sourasky Medical Center",
            "Klinik Hirslanden, Zurich",
            "CHU de Brest",
            "Cardiovascular Imaging Technologies",
            "Arthritis Program, Toronto Western Hospital",
            "Alkermes, Inc.",
            "Eli Lilly and Company",
            "GlaxoSmithKline",
            "Erasme hospital",
            "Hôpital Cochin, Paris",
            "Tokyo University",
            "University Hospital Aachen - Germany",
            "Boehringer Ingelheim",
            "University of Maryland Greenebaum Cancer Center",
            "University of Nebraska",
            "Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany",
            "Cephalon",
            "Cancer and Leukemia Group B",
            "Xuanwu Hospital, Beijing",
            "University of Miami Sylvester Comprehensive Cancer Center",
            "Director CES-LPH Research Group",
            "Stanford University",
            "Academic Medical Centre (Amsterdam)",
            "UroGen Pharma",
            "Thomas Jefferson University",
            "North Central Cancer Treatment Group",
            "Ambrilia Biopharma, Inc.",
            "Med. Klinik V, University Hospital Heidelberg",
            "National Taiwan University Hospital",
            "Impel NeuroPharma, Seattle, WA (USA)",
            "Fuda Cancer Hospital, Guangzhou",
            "Henry Ford Health System",
            "Nationwide Children's Hospital",
            "Mayo Clinic in Rochester",
            "Dana-Farber Cancer Institute",
            "French Innovative Leukemia Organisation",
            "Alicante General University Hospital",
            "Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni",
            "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
            "Radiant Research",
            "Beijing Ditan Hospital",
            "Hospitales Universitarios Virgen del Rocío",
            "Assistance Publique - Hôpitaux de Paris",
            "Department of HPH Surgery, National Liver Institute, University of Menoufia, Egypt",
            "Regeneron Pharmaceuticals"
          ],
          [
            "Pierre Fabre Medicament",
            "Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium",
            "Tennessee Oncology / Sarah Cannon",
            "Rutgers Cancer Institute of New Jersey"
          ],
          [
            "Texas Heart Institute/St. Luke's Hospital",
            "New York Medical College",
            "Tri-Service General Hospital",
            "Hôpital Européen Georges Pompidou, Oncology Department",
            "New York Presbyterian Hospital, New York, NY 10021, United States"
          ]
        ],
        "p2_terminate_reason": {
          "Northwestern University": "Adverse event before starting treatment",
          "M.D. Anderson Cancer Center": "Death",
          "Fred Hutch/University of Washington Cancer Consortium": "Adverse Event",
          "Biogen": "Adverse Event",
          "ECOG-ACRIN Cancer Research Group": "Adverse Event",
          "Ipsen": "Adverse Event",
          "Hoffmann-La Roche": "Adverse Event",
          "University of Nebraska": "Ineiligible",
          "Eastern Cooperative Oncology Group": "Patient ineligible"
        },
        "p2_withdraw_reason": {},
        "p2_adverse_event": {
          "Stanford University": 0.9428571428571428,
          "Hoffmann-La Roche": 0.2631578947368421,
          "Mayo Clinic": 0.0,
          "Novartis Pharmaceuticals": 0.3333333333333333,
          "Boehringer Ingelheim": 0.0,
          "Northwestern University": 0.44,
          "Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium": 0.2916666666666667,
          "University of Miami Sylvester Comprehensive Cancer Center": 0.125,
          "Montefiore Medical Center": 0.027777777777777776,
          "Rady Children's Hospital": 0.012195121951219513,
          "The University of Chicago Medical Center": 0.2463768115942029,
          "University of Pittsburgh": 0.265625,
          "Dana-Farber Cancer Institute": 0.0,
          "M.D. Anderson Cancer Center": 0.6666666666666666,
          "University of California, San Francisco": 0.25,
          "GlaxoSmithKline": 0.0,
          "Case Comprehensive Cancer Center": 0.0,
          "North Central Cancer Treatment Group": 0.3333333333333333,
          "Ohio State University Comprehensive Cancer Center": 0.0,
          "University of Washington": 0.1875,
          "Mayo Clinic in Minnesota": 0.0,
          "Nationwide Children's Hospital": 0.037037037037037035,
          "Merck Sharp & Dohme Corp.": 0.0,
          "Erasme hospital": 0.45977011494252873,
          "Pfizer": 1.0,
          "Thomas Jefferson University": 0.45454545454545453,
          "Alkermes, Inc.": 0.0,
          "University of Arizona": 0.2,
          "Cancer and Leukemia Group B": 0.18627450980392157,
          "Fred Hutch/University of Washington Cancer Consortium": 0.25,
          "Biogen": 0.06060606060606061,
          "ECOG-ACRIN Cancer Research Group": 1.0,
          "Ipsen": 0.125,
          "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins": 0.5858585858585859,
          "Washington University School of Medicine": 0.6666666666666666,
          "Memorial Sloan Kettering Cancer Center": 0.3333333333333333,
          "OHSU Knight Cancer Institute": 0.46153846153846156,
          "Alliance for Clinical Trials in Oncology": 0.3333333333333333,
          "Impel NeuroPharma, Seattle, WA (USA)": 0.0,
          "Roswell Park Cancer Institute": 0.1,
          "Indiana University Melvin and Bren Simon Cancer Center": 1.0,
          "Bristol-Myers Squibb": 0.22105263157894736,
          "National Cancer Institute (NCI)": 0.42857142857142855,
          "Southwest Oncology Group": 0.42857142857142855,
          "AIDS Associated Malignancies Clinical Trials Consortium": 0.5490196078431373,
          "Radiant Research": 0.0,
          "University of Nebraska": 0.5,
          "City of Hope Medical Center": 0.01639344262295082,
          "Eastern Cooperative Oncology Group": 0.7096774193548387,
          "Sanofi": 0.0,
          "Children's Oncology Group": 0.043478260869565216
        },
        "p3_company_num": 59,
        "p3_stat_company_num": [2, 11, 0, 6, 2, 6, 28, 0, 4],
        "p3_company": [
          [
            "Vanderbilt University Medical Center",
            "Alicante General University Hospital"
          ],
          [
            "Oregon Health and Science University",
            "Alliance Foundation Trials, LLC.",
            "Centre Antoine Lacassagne",
            "Northern Jiangsu Province People's Hospital",
            "Velindre NHS Trust",
            "CPC Clinical Research",
            "VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA",
            "Southwest Oncology Group",
            "Assistance Publique - Hôpitaux de Paris",
            "Eli Lilly and Company",
            "Attending Physician, Emergency Department"
          ],
          [],
          [
            "Fondazione EMN Italy Onlus",
            "University of Oxford",
            "Radius Health, Inc.",
            "Mayo Clinic in Rochester",
            "Med. Klinik V, University Hospital Heidelberg",
            "Justus-Liebig University of Giessen"
          ],
          [
            "Children's Oncology Group",
            "Alliance for Clinical Trials in Oncology"
          ],
          [
            "City of Hope Medical Center",
            "Centre Hospitalier Intercommunal Créteil",
            "Ambrilia Biopharma, Inc.",
            "CUHK",
            "Hôpital Cochin, Paris",
            "Weill Medical College of Cornell University, New York Hospital Department of Neurology"
          ],
          [
            "Novartis Pharmaceuticals",
            "M.D. Anderson Cancer Center",
            "Hospital Universitario Central de Asturias",
            "Laser Center",
            "Princess Margaret Hospital, Canada",
            "CHU de Brest",
            "Toronto Sunnybrook Regional Cancer Centre",
            "National Taiwan University Hospital",
            "Sponsor GmbH",
            "Mayo Clinic",
            "Henry Ford Health System",
            "Dana-Farber Cancer Institute",
            "University of California, San Diego",
            "GlaxoSmithKline",
            "Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni",
            "University of Michigan",
            "Centre d'Oncologie de Gentilly - Nancy - France",
            "Tokyo University",
            "University of Nebraska",
            "Amphastar Pharmaceuticals, Inc.",
            "Beijing Ditan Hospital",
            "Hoffmann-La Roche",
            "Abbott",
            "Hospitales Universitarios Virgen del Rocío",
            "Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany",
            "Cephalon",
            "Pfizer",
            "Regeneron Pharmaceuticals"
          ],
          [],
          [
            "Sun Yat-sen Memorial Hospital,Sun Yat-sen University",
            "AMES Technology Inc./ Oregon Health and Science University",
            "Xuanwu Hospital, Beijing",
            "PALG"
          ]
        ],
        "p3_terminate_reason": {
          "Hoffmann-La Roche": "Adverse Event",
          "Weill Medical College of Cornell University, New York Hospital Department of Neurology": "Withdrawal by Subject"
        },
        "p3_withdraw_reason": {},
        "p3_adverse_event": {
          "Mayo Clinic": 0.0625,
          "Hoffmann-La Roche": 0.3113207547169811,
          "Novartis Pharmaceuticals": 0.35443037974683544,
          "City of Hope Medical Center": 0.0,
          "Eli Lilly and Company": 0.030612244897959183,
          "Weill Medical College of Cornell University, New York Hospital Department of Neurology": 0.03571428571428571
        }
      }
    },
    {
      "id": 16,
      "paper_title": "Ring-opening of five-membered heterocycles conjugated 4-isopropylresorcinol scaffold-based benzamides as HSP90 inhibitors suppressing tumor growth in vitro and in vivo",
      "paper_author": [
        "Yi-Min Liu",
        "Huang-Ju Tu",
        "Chueh-Heng Wu",
        "Mei-Jung Lai",
        "Shu-Chieh Yu",
        "Min-Wu Chao",
        "Yi-Wen Wu",
        "Che-Ming Teng",
        "Shiow-Lin Pan",
        "Jing-Ping Liou"
      ],
      "paper_year": 2021,
      "paper_institution": "School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan",
      "paper_cited": 0,
      "doi": "10.1016/j.ejmech.2021.113428",
      "paper_journal": "European Journal of Medicinal Chemistry",
      "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002774-ga1_lrg.jpg",
      "compound_count": 45,
      "compound_name": "6b",
      "compound_name_drug": "",
      "compound_smiles": "c1(cnccc1)N(C(=O)c1c(cc(O)c(C(C)C)c1)O)CC",
      "medicinal_chemistry_metrics": {
        "Ki": 200.0,
        "Kd": 0.0,
        "IC50": 50.0,
        "selectivity": 0
      },
      "pharm_metrics_vitro": {
        "Ki": 0.0,
        "Kd": 0.0,
        "IC50": 110.18,
        "EC50": 0.0,
        "selectivity": 0,
        "hERG": 0.0,
        "solubility": 0.0
      },
      "pharm_metrics_vivo": {
        "ED50": 0.0,
        "AUC": 0.0,
        "solubility": 0.0,
        "t_half": 16.4,
        "bioavailability": 17.8
      },
      "clinical_statistics": {}
    }
  ],
  "medicinal_chemistry_similarity": [
    { "source": 0, "target": 1, "value": 0.46650859513930054 },
    { "source": 0, "target": 2, "value": 0.12426532325776658 },
    { "source": 0, "target": 3, "value": 0.48257080610021785 },
    { "source": 0, "target": 4, "value": 0.4034861200774693 },
    { "source": 0, "target": 5, "value": 0.4804597701149425 },
    { "source": 0, "target": 6, "value": 0.4761640798226164 },
    { "source": 0, "target": 7, "value": 0.4450227716330514 },
    { "source": 0, "target": 8, "value": 0.40888308295231873 },
    { "source": 0, "target": 9, "value": 0.4937192790824686 },
    { "source": 0, "target": 10, "value": 0.25188536953242835 },
    { "source": 0, "target": 11, "value": 0.4761640798226164 },
    { "source": 0, "target": 12, "value": 0.3176815847395451 },
    { "source": 0, "target": 13, "value": 0.43797766019988243 },
    { "source": 0, "target": 14, "value": 0.3118121790168745 },
    { "source": 0, "target": 15, "value": 0.3118121790168745 },
    { "source": 0, "target": 16, "value": 0.3594306049822064 },
    { "source": 1, "target": 2, "value": 0.12447257383966245 },
    { "source": 1, "target": 3, "value": 0.6145100162425555 },
    { "source": 1, "target": 4, "value": 0.4653822998193859 },
    { "source": 1, "target": 5, "value": 0.547190398254228 },
    { "source": 1, "target": 6, "value": 0.5774419859686994 },
    { "source": 1, "target": 7, "value": 0.4697867298578199 },
    { "source": 1, "target": 8, "value": 0.45602409638554214 },
    { "source": 1, "target": 9, "value": 0.595631326584976 },
    { "source": 1, "target": 10, "value": 0.2690019828155982 },
    { "source": 1, "target": 11, "value": 0.5774419859686994 },
    { "source": 1, "target": 12, "value": 0.31541906589891233 },
    { "source": 1, "target": 13, "value": 0.5142697257974258 },
    { "source": 1, "target": 14, "value": 0.29949238578680204 },
    { "source": 1, "target": 15, "value": 0.29949238578680204 },
    { "source": 1, "target": 16, "value": 0.3769035532994924 },
    { "source": 2, "target": 3, "value": 0.12075242718446602 },
    { "source": 2, "target": 4, "value": 0.12858384013900956 },
    { "source": 2, "target": 5, "value": 0.11687458962573867 },
    { "source": 2, "target": 6, "value": 0.1133250311332503 },
    { "source": 2, "target": 7, "value": 0.12635983263598327 },
    { "source": 2, "target": 8, "value": 0.12852112676056338 },
    { "source": 2, "target": 9, "value": 0.11644657863145258 },
    { "source": 2, "target": 10, "value": 0.16124260355029585 },
    { "source": 2, "target": 11, "value": 0.1133250311332503 },
    { "source": 2, "target": 12, "value": 0.13985148514851486 },
    { "source": 2, "target": 13, "value": 0.12455261274158912 },
    { "source": 2, "target": 14, "value": 0.14554579673776663 },
    { "source": 2, "target": 15, "value": 0.14554579673776663 },
    { "source": 2, "target": 16, "value": 0.1423841059602649 },
    { "source": 3, "target": 4, "value": 0.4760594386351128 },
    { "source": 3, "target": 5, "value": 0.6171997902464604 },
    { "source": 3, "target": 6, "value": 0.6472727272727272 },
    { "source": 3, "target": 7, "value": 0.484766050054407 },
    { "source": 3, "target": 8, "value": 0.4626783754116356 },
    { "source": 3, "target": 9, "value": 0.673374613003096 },
    { "source": 3, "target": 10, "value": 0.27379553466509987 },
    { "source": 3, "target": 11, "value": 0.6472727272727272 },
    { "source": 3, "target": 12, "value": 0.3279538904899135 },
    { "source": 3, "target": 13, "value": 0.5864661654135338 },
    { "source": 3, "target": 14, "value": 0.31878230901780585 },
    { "source": 3, "target": 15, "value": 0.31878230901780585 },
    { "source": 3, "target": 16, "value": 0.38250428816466553 },
    { "source": 4, "target": 5, "value": 0.46251441753171857 },
    { "source": 4, "target": 6, "value": 0.4894946053378762 },
    { "source": 4, "target": 7, "value": 0.3622735790131168 },
    { "source": 4, "target": 8, "value": 0.47938504542278126 },
    { "source": 4, "target": 9, "value": 0.47428884026258206 },
    { "source": 4, "target": 10, "value": 0.2328767123287671 },
    { "source": 4, "target": 11, "value": 0.4894946053378762 },
    { "source": 4, "target": 12, "value": 0.2715423606082549 },
    { "source": 4, "target": 13, "value": 0.4546553808948005 },
    { "source": 4, "target": 14, "value": 0.2703488372093023 },
    { "source": 4, "target": 15, "value": 0.2703488372093023 },
    { "source": 4, "target": 16, "value": 0.3022284122562674 },
    { "source": 5, "target": 6, "value": 0.6219839142091153 },
    { "source": 5, "target": 7, "value": 0.46014697569248164 },
    { "source": 5, "target": 8, "value": 0.4619849100406268 },
    { "source": 5, "target": 9, "value": 0.6368921775898521 },
    { "source": 5, "target": 10, "value": 0.27329974811083124 },
    { "source": 5, "target": 11, "value": 0.6219839142091153 },
    { "source": 5, "target": 12, "value": 0.32068543451652387 },
    { "source": 5, "target": 13, "value": 0.5454045129334067 },
    { "source": 5, "target": 14, "value": 0.3149847094801223 },
    { "source": 5, "target": 15, "value": 0.3149847094801223 },
    { "source": 5, "target": 16, "value": 0.37947783849423194 },
    { "source": 6, "target": 7, "value": 0.48333333333333334 },
    { "source": 6, "target": 8, "value": 0.48659440958357103 },
    { "source": 6, "target": 9, "value": 0.6828752642706131 },
    { "source": 6, "target": 10, "value": 0.262874251497006 },
    { "source": 6, "target": 11, "value": 1.0 },
    { "source": 6, "target": 12, "value": 0.3037166085946574 },
    { "source": 6, "target": 13, "value": 0.5785169029443838 },
    { "source": 6, "target": 14, "value": 0.3347255369928401 },
    { "source": 6, "target": 15, "value": 0.3347255369928401 },
    { "source": 6, "target": 16, "value": 0.38846380223660976 },
    { "source": 7, "target": 8, "value": 0.46711864406779663 },
    { "source": 7, "target": 9, "value": 0.48698481561822127 },
    { "source": 7, "target": 10, "value": 0.2600151171579743 },
    { "source": 7, "target": 11, "value": 0.48333333333333334 },
    { "source": 7, "target": 12, "value": 0.3008658008658009 },
    { "source": 7, "target": 13, "value": 0.45665083135391926 },
    { "source": 7, "target": 14, "value": 0.3276627218934911 },
    { "source": 7, "target": 15, "value": 0.3276627218934911 },
    { "source": 7, "target": 16, "value": 0.45007564296520425 },
    { "source": 8, "target": 9, "value": 0.5053400786958966 },
    { "source": 8, "target": 10, "value": 0.23023791250959325 },
    { "source": 8, "target": 11, "value": 0.48659440958357103 },
    { "source": 8, "target": 12, "value": 0.2730600292825769 },
    { "source": 8, "target": 13, "value": 0.49405878674171355 },
    { "source": 8, "target": 14, "value": 0.30641509433962266 },
    { "source": 8, "target": 15, "value": 0.30641509433962266 },
    { "source": 8, "target": 16, "value": 0.3188612099644128 },
    { "source": 9, "target": 10, "value": 0.26949941792782306 },
    { "source": 9, "target": 11, "value": 0.6828752642706131 },
    { "source": 9, "target": 12, "value": 0.31200453001132505 },
    { "source": 9, "target": 13, "value": 0.6072589382448538 },
    { "source": 9, "target": 14, "value": 0.3209382151029748 },
    { "source": 9, "target": 15, "value": 0.3209382151029748 },
    { "source": 9, "target": 16, "value": 0.3573422668900056 },
    { "source": 10, "target": 11, "value": 0.262874251497006 },
    { "source": 10, "target": 12, "value": 0.35737704918032787 },
    { "source": 10, "target": 13, "value": 0.24884488448844885 },
    { "source": 10, "target": 14, "value": 0.3369447453954496 },
    { "source": 10, "target": 15, "value": 0.3369447453954496 },
    { "source": 10, "target": 16, "value": 0.2988505747126437 },
    { "source": 11, "target": 12, "value": 0.3037166085946574 },
    { "source": 11, "target": 13, "value": 0.5785169029443838 },
    { "source": 11, "target": 14, "value": 0.3347255369928401 },
    { "source": 11, "target": 15, "value": 0.3347255369928401 },
    { "source": 11, "target": 16, "value": 0.38846380223660976 },
    { "source": 12, "target": 13, "value": 0.30166880616174585 },
    { "source": 12, "target": 14, "value": 0.30228136882129275 },
    { "source": 12, "target": 15, "value": 0.30228136882129275 },
    { "source": 12, "target": 16, "value": 0.34900542495479203 },
    { "source": 13, "target": 14, "value": 0.3049095607235142 },
    { "source": 13, "target": 15, "value": 0.3049095607235142 },
    { "source": 13, "target": 16, "value": 0.36086404066073696 },
    { "source": 14, "target": 15, "value": 1.0 },
    { "source": 14, "target": 16, "value": 0.37662337662337664 },
    { "source": 15, "target": 16, "value": 0.37662337662337664 }
  ],
  "metrics_paper_count": {
    "IC50_MC": 15,
    "Ki_MC": 2,
    "Kd_MC": 4,
    "Selectivity_MC": 0,
    "IC50_Ph": 9,
    "Ki_Ph": 0,
    "Kd_Ph": 1,
    "EC50_Ph": 1,
    "Selectivity_Ph": 0,
    "hERG_Ph": 1,
    "solubility_Ph": 5,
    "ED50_Cl": 0,
    "thalf_Cl": 8,
    "AUC_Cl": 7,
    "bio_Cl": 8,
    "solubility_Cl": 0,
    "adverse_1": 267,
    "adverse_2": 197,
    "adverse_3": 62
  },
  "metrics_distribution": {
    "IC50_MC": [
      15.0, 880.0, 260.0, 8000.0, 0.08, 5.0, 0.4, 5.8, 300.0, 1870.0, 2600.0,
      37.0, 1.5, 5010.0, 50.0
    ],
    "Ki_MC": [3700.0, 200.0],
    "Kd_MC": [16.0, 38.0, 75.0, 9.0],
    "Selectivity_MC": [],
    "IC50_Ph": [8000.0, 20.0, 44.0, 68.0, 790.0, 2600.0, 274.0, 193.53, 110.18],
    "Ki_Ph": [],
    "Kd_Ph": [5480.0],
    "EC50_Ph": [21.0],
    "Selectivity_Ph": [],
    "hERG_Ph": [50000.0],
    "solubility_Ph": [84.0, 120000.0, 423.0, 25.2, 10000.0],
    "ED50_Cl": [],
    "thalf_Cl": [5.1, 50.0, 6.5, 1.4, 0.5, 1.6, 3.6, 16.4],
    "AUC_Cl": [4710.0, 15.9, 628.5, 1.0, 169.0, 3144.0, 8380.0],
    "bio_Cl": [100.0, 62.9, 94.0, 48.0, 3.6, 28.0, 22.5, 17.8],
    "solubility_Cl": [],
    "adverse_1": [0.0, 0.5, 0.0, 0.0, 0.4482758620689655, 0.6666666666666666],
    "adverse_2": [
      0.9428571428571428, 0.2631578947368421, 0.0, 0.3333333333333333, 0.0,
      0.44, 0.2916666666666667, 0.125, 0.027777777777777776,
      0.012195121951219513, 0.2463768115942029, 0.265625, 0.0,
      0.6666666666666666, 0.25, 0.0, 0.0, 0.3333333333333333, 0.0, 0.1875, 0.0,
      0.037037037037037035, 0.0, 0.45977011494252873, 1.0, 0.45454545454545453,
      0.0, 0.2, 0.18627450980392157, 0.25, 0.06060606060606061, 1.0, 0.125,
      0.5858585858585859, 0.6666666666666666, 0.3333333333333333,
      0.46153846153846156, 0.3333333333333333, 0.0, 0.1, 1.0,
      0.22105263157894736, 0.42857142857142855, 0.42857142857142855,
      0.5490196078431373, 0.0, 0.5, 0.01639344262295082, 0.7096774193548387,
      0.0, 0.043478260869565216
    ],
    "adverse_3": [
      0.0625, 0.3113207547169811, 0.35443037974683544, 0.0,
      0.030612244897959183, 0.03571428571428571
    ]
  }
}
